Last updated on May 2019

The Benefit of Hemodialysis Plus Hemoperfusion on Mortality


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Chronic renal failure
  • Age: Between 18 - 75 Years
  • Gender: Male or Female

Patients must meet all of the following criteria are eligible:

  1. Age at 18-75 years old
  2. Regular blood purification treatment at least 3 months before enrolled in this study
  3. Standard Kt/V 1.2

Subjects with one of more of the following conditions will be excluded:

  1. White blood cell count < 410^9/L and / or platelet count < 10010^9/L
  2. Cerebral hemorrhage in the past 12 weeks
  3. MACEs in the past 8 weeks
  4. Severe heart failure (New York Heart Association [NYHA] class III or IV)
  5. Active gastrointestinal bleeding, or coagulation dysfunction
  6. Malignant tumor
  7. Active infection
  8. Pregnancy or lactation
  9. Participating in clinical trials in the past 3 months 10) Mental disabilities

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.